3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
3
Completed
3
Active not recruiting
3
Suspended
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
1
Interventions
Specimen Handling
22
Magnetic Resonance Spectroscopy
20
Carboplatin
17
Gemcitabine
15
pembrolizumab
13
Cisplatin
13
Paclitaxel
12
Injections
11
Interviews as Topic
10
fludarabine
9
Radiotherapy
9
Cyclophosphamide
9
Oxaliplatin
8
Dexamethasone
8
Biopsy
8
Bevacizumab
8
toripalimab
7
Nivolumab
7
Irinotecan
7
Fluorouracil
7
Bortezomib
7
X-Rays
6
Radiosurgery
6
Pemetrexed
6
Leucovorin
6
Capecitabine
6
durvalumab
5
cemiplimab
5
anlotinib
5
Doxorubicin
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
regorafenib
×
30 days
×
Clear all
NCT07495579
2026-05-27
REVIVE
Asan Medical Center
Phase 2
Not yet recruiting
146 enrolled